NCT00230113View on ClinicalTrials.gov

Effect of Omega-3 PUFA Supplementation in NAFLD Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

Omega-3 fatty acid diet supplementation

4 gm fish oil per day

DIETARY_SUPPLEMENT

safflower oil

4 gm per day safflower oil

Trial Locations (1)

98195

University of Washington Medical Center, Seattle

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00230113 - Effect of Omega-3 PUFA Supplementation in NAFLD Patients | Biotech Hunter | Biotech Hunter